0001209191-17-057532.txt : 20171019 0001209191-17-057532.hdr.sgml : 20171019 20171019213302 ACCESSION NUMBER: 0001209191-17-057532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171017 FILED AS OF DATE: 20171019 DATE AS OF CHANGE: 20171019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crowley John F CENTRAL INDEX KEY: 0001400973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33497 FILM NUMBER: 171145846 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC CENTRAL INDEX KEY: 0001178879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200422823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 BUSINESS PHONE: (609) 662-2000 MAIL ADDRESS: STREET 1: 1 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-17 0 0001178879 AMICUS THERAPEUTICS INC FOLD 0001400973 Crowley John F C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 1 1 0 0 Chairman & CEO Common Stock 2017-10-17 4 M 0 52722 14.75 A 380723 D Common Stock 2017-10-17 4 S 0 52722 14.75 D 328001 D Common Stock 2017-10-18 4 M 0 19013 14.7554 A 347014 D Common Stock 2017-10-18 4 S 0 19013 14.7554 D 328001 D Common Stock 64895 I By Trust Stock Options (right to buy) 3.53 2017-10-17 4 M 0 52722 0.00 D 2017-01-28 2023-01-28 Common Stock 52722 39521 D Stock Options (right to buy) 3.53 2017-10-18 4 M 0 19013 0.00 D 2017-01-28 2023-01-28 Common Stock 19013 20508 D The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.75 to $14.79. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares were sold to fund the "Megan K. Crowley 2016 Special Needs Trust", a trust for the benefit of Mr. Crowley's child, with the balance of the proceeds used for general estate planning purposes. The total shares sold represented less than 2% of Mr. Crowley's holdings of securities of the company. /s/ John F. Crowley 2017-10-19